Vivace Therapeutics has closed $35m in a Series D financing round to support the clinical development of its cancer drug ...

Driven Platform to Shape Future of Recruiting NEW YORK, March 3, 2025 /PRNewswire/ -- HeyMilo, an AI-powered candidate screening platform, today announced $2.2 million in seed funding. The round, led ...

SAN FRANCISCO, Feb. 18, 2025 /PRNewswire/ -- Valid, the AI-enabled ad agency transforming digital advertising, today announced $5.5 million in seed funding led by Canaan Partners. Neo, J Ventures ...

Financing Led by RA Capital Management with Participation from Other Existing Investors Canaan Partners and Cenova Capital VT3989 is the Only TEAD Autopalmitoylation Inhibitor ...

Canaan Partners (Rowayton, Connecticut and Menlo Park, Calif.) led the investment, with Series A investor New Enterprise Associates (Menlo Park) participating. Jim Furnivall, general partner of Canaan ...

Vivace Therapeutics Inc. closed a $35 million series D round led by RA Capital Management, an existing investor, and including other backers already on board: Canaan Partners and Cenova Capital.

Canaan, Inc. is a holding company, which engages in developing and selling Bitcoin mining machines and related services. It focuses on the development of green mining. The company was founded by ...

The round, led by Canaan Partners, underscores the growing demand for innovative technologies that streamline recruitment and unlock efficiencies in talent acquisition. Additional participation ...